Tyra Biosciences, Inc.
TYRA
$12.16
$0.4553.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 27.50M | 25.89M | 24.13M | 21.52M | 20.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 121.65M | 113.73M | 104.20M | 100.09M | 95.45M |
| Operating Income | -121.65M | -113.73M | -104.20M | -100.09M | -95.45M |
| Income Before Tax | -105.83M | -96.44M | -86.48M | -83.74M | -80.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -105.83 | -96.44 | -86.48 | -83.74 | -80.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -105.83M | -96.44M | -86.48M | -83.74M | -80.88M |
| EBIT | -121.65M | -113.73M | -104.20M | -100.09M | -95.45M |
| EBITDA | -121.10M | -113.19M | -103.68M | -99.62M | -95.02M |
| EPS Basic | -1.79 | -1.63 | -1.51 | -1.61 | -1.69 |
| Normalized Basic EPS | -1.12 | -1.02 | -0.94 | -1.00 | -1.06 |
| EPS Diluted | -1.79 | -1.63 | -1.51 | -1.61 | -1.69 |
| Normalized Diluted EPS | -1.12 | -1.02 | -0.94 | -1.00 | -1.06 |
| Average Basic Shares Outstanding | 236.82M | 235.94M | 228.83M | 212.74M | 196.73M |
| Average Diluted Shares Outstanding | 236.82M | 235.94M | 228.83M | 212.74M | 196.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |